Last reviewed · How we verify
Pediatric Exploratory Research Study of EGCG Use and Safety (PERSEUS)
To evaluate safety and tolerability of epigallocatechin gallate (EGCG) in children from 6 to 12 years old with Intellectual Developmental Disorders (IDD) (Down syndrome or Fragile X syndrome).
Details
| Lead sponsor | Parc de Salut Mar |
|---|---|
| Phase | NA |
| Status | COMPLETED |
| Enrolment | 76 |
| Start date | Mon Jan 29 2018 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Mon Nov 30 2020 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Down Syndrome
- Fragile X Syndrome
Interventions
- EGCG FontUp
- Placebo FontUp
Countries
Spain